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Petasis/Diels-Alder/Cyclization Cascade Reactions for the 
Generation of Scaffolds with Multiple Stereogenic Centers and 
Orthogonal Handles for Library Production 
Thomas Flagstad,[a,b][‡] Carlos M. G. Azevedo,[a,b][‡] Geanna Min,[a,b] Anthony Willaume,[c] Rémy 
Morgentin,[c] Thomas E. Nielsen,[a,d]*, Mads H. Clausen[a,b]* 
Abstract: A new effective strategy for the synthesis of sp3-rich small 
molecules for library production is presented. The key steps to 
generate complexity involve Petasis 3-component reaction followed 
by an intramolecular Diels-Alder and cyclization to generate a densely 
enriched tricyclic or tetracyclic scaffolds with 3-4 stereocenters with 3 
handles for decoration. The strategy was used for the production of 
143 molecules for the European Lead Factory. 
Introduction 
The impact of small organic molecules on quality-of-life in 
modern society cannot be understated. In fact, most marketed 
drugs are small organic molecules, which in 2017 comprised 
34 out of 46 new FDA approved drugs.[1] Current libraries for 
high-throughput screening (HTS) are highly populated with 
flat aromatic scaffolds, containing a high percentage of sp2 
hybridized carbons and few stereocenters, representing the 
adoption of robust sp2-sp2 cross-coupling reactions by the 
drug discovery community.[2] Therefore, there is a need for 
novel 3-dimensionally complex structures, which occupy a 
different area of chemical space. Molecules containing a high 
percentage of sp3 hybridized carbon atoms are known to have 
favorable drug-like properties and higher possibility of 
reaching the clinic.[2b] In comparison of aliphatic and 
aromatic heterocycles, the former have a better 
pharmacokinetic profile.[3] The synthesis of libraries 
containing molecules with several stereocenters and a high 
percentage of sp3 carbons from readilly accessible building 
blocks is challenging, and our group have engaged in efforts 
to develop novel and reliable methods for their synthesis.[4] 
Some of the libraries have been included in the public 
compound collection (PCC) of the European Lead Factory 
(ELF), a private-public European partnership involving 
pharmaceutical companies, small and medium enterprises 
(SMEs), and universities that aim the discovery of new and 
innovative leads for drug discovery.[5] The PCC intends to 
explore an underepresented area of chemical space by the 
production of three-dimensionally complex scaffolds, and so 
far, PCC scaffolds have a higher percentage of sp3 hybridized 
carbons when compared to other commercial and corporate 
screening compound collections.[6] 
Herein, we present a short, efficient and versatile synthetic 
strategy for library production of complex tricyclic and 
tetracyclic scaffolds (Scheme 1). The strategy relies on the 
use of the Petasis 3-component reaction[7] followed by an 
amide coupling and an intramolecular Diels-Alder reaction to 
create a core rich in sp3 carbons and stereocenters (Scheme 1, 
A).[8] Oxidative cleavage followed by aldehyde reduction 
generates a diol (Scheme 1, B), which can be cyclized 
intramolecularly to generate a pyrrolidinone ring (Scheme 1, 
C). The free hydroxyl can then be used either for further 
diversification (Scheme 1, D) or cyclized again to give a spiro 
azetidine ring (Scheme 1, E). 
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Scheme 1. A Petasis/Diels-Alder/cyclization strategy for library synthesis 
Results and Discussion 
The synthetic route started with a Petasis 3-component 
reaction[7] between a furanyl boronic acid, 
allylbenzylamine and glyoxylic acid to give an amino acid 
intermediate. This was coupled with various amines and 
subjected to refluxing THF or acetonitrile to produce 
compounds 1a-1f in good yields (47–67%, over three 
steps). The alkene was dihydroxylated using catalytic 
osmium and NMO as re-oxidant to generate the syn-diols 
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2a, 2c and 2d in good to excellent yields (73–92%). The diol 
was oxidatively cleaved using NaIO4 followed by reduction 
of the formed dialdehyde, to afford the diol in good yields for 
cyclohexyl and butyl (3a and 3c), and a moderate yield for 
the cyclopropyl analogue (3d). The oxidation, oxidative 
cleavage and reduction could also be achieved in a 3-step 
fashion, which was performed for alkenes 1b, 1e and 1f, 
which gave the diols 3b, 3e and 3f in moderate to good yields 
(44–70% over three steps).  
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Scheme 2. Petasis/Acylation/Diels-Alder followed by oxidative cleavage and 
aldehyde reduction generating 3a-3f. 
After establishing an efficient protocol for the synthesis of the 
diols, we set out to investigate the ring closure-substitution 
sequence. Initially, reductive cyclization of the dialdehyde 
intermediate was attempted but only led to complex reaction 
mixtures without formation of the desired compounds. Thus, 
it was decided to start from the diol instead. The first attempt 
was to investigate Mitsunobu-chemistry as the cyclization 
strategy, which generally only gave trace amounts of product 
and many side products. Ultimately, we investigated turning 
the two alcohols into leaving groups. While conversion to a 
dichloride gave several by-products, it was found out that 
dimesylation was a good starting point for cyclization 
processes. The dimesylate 4a (Scheme3) was obtained in 
quantitative yield from the diol, and by subsequent treatment 
with NaH, the cyclized compound 5a could be isolated in 
excellent yields (94%, over two steps), having a mesylate-
group ready for functionalization. In case of compound 3f, 
mesylation of the diol followed by deprotection of the amine 
and treatment with NaH, led to the synthesis of the desired 
product in 35 % yield. We then explored the scope of 
mesylate substitution by allowing compound 5a to react with 
different O and N nucleophiles (Scheme 3). The mesylate 
could be substituted with pyrrolidine (6a), phenol (7a) and 
phthalimide (8a) in 53% to 71% yields (Scheme 3). 
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Scheme 3. Cyclization of 3a and 3f 
For library production of the tricyclic scaffold, we decided to 
focus on the phenol and phthalimide, the latter providing 
further access to two orthogonal vectors by either 
functionalization of the pyrrolidine nitrogen obtained from 
benzyl deprotection, or the primary nitrogen resulting from 
phthalimide deprotection. To investigate the best conditions 
for library production, a subset of compounds with different 
substituents (Scheme 4, 7b–7e, 8b and 8c) were synthesized 
in moderate to good yields (28-82%). Cyclopropyl derivative 
(7d) did not give good yields in the early steps, and as a result 
it was not carried forward for library production.  
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Scheme 4. Cyclization and functionalization of 3b–3e 
The benzyl group was removed either by 1-chloroethyl 
chloroformate or hydrogenation with Pd(OH)2/C, and the 
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resulting product used directly in the next step. The 
pyrrolidine amine reacted with isocyanates, sulfonyl 
chlorides, acyl chlorides and aldehydes/NaBH(OAc)3 to 
provide a small library of compounds with different 
functionalities (Scheme 5). To demonstrate the orthogonality 
of the two nitrogen protecting groups, 8c was N-debenzylated 
and the respective amine functionalized with 3-chlorophenyl 
isocyanate and 4-toluenesulfonyl chloride to give 11d and 
12e (Scheme 5), respectively. 
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Scheme 5. Production of the first library 
The second library was generated from the removal of the 
phthalimide with hydrazine to give a primary amine, which 
was used directly in library production. It was decorated with 
ureas, sulfonamides, amides and two methyl groups by 
reaction with isocyanates, sulfonyl chlorides, acyl chlorides 
and formaldehyde/NaBH(OAc)3, respectively (Scheme 6). 
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Scheme 6. Production of the second library 
 
The optimized conditions were used to synthesize a library 
for HTS. Considering the low molecular weight of the core 
scaffold (180 for the tricyclic scaffold) and low clog P, it 
allowed the synthesis of a library of 143 compounds with a  
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molecular weight between 325 and 525, an Fsp3 between 0.28 
and 0.67, and clog P below 5. The properties of the 143 
compounds are shown in Figure 1. 
 
Figure 1. Physicochemical properties of the library compounds 
Conclusions 
In conclusion, a robust method for the synthesis of highly 
complex tricyclic and tetracyclic scaffolds with high Fsp3 and 
several stereocenters using cheap and readily available 
starting materials was developed. A library of 143 
compounds was produced and will be used for HTS in the 
ELF. 
Experimental Section 
Representative procedure for the Petasis 3-component reaction, 
amide coupling and Diels-Alder sequence. (3R,3aR,6R,7aR)-2-benzyl-
N-cyclohexyl-1,2,3,6,7,7a-hexahydro-3a,6-epoxyisoindole-3-
carboxamide (1a). N-Allylbenzyl amine (3.70 g, 25.1 mmol) and glyoxylic 
acid monohydrate (3.47 g, 37.7 mmol) were dissolved in CH2Cl2 (25 mL, 1 
M) and the mixture was cooled to 0 °C. To the mixture was added 2-
furanylboronic acid (4.22 g, 37.7 mmol) portion wise and the mixture was 
stirred 10 min at 0 °C and 50 min at rt. Then CH2Cl2 (50 mL) and H2O (75 
mL) was added and the layers separated. The aqueous phase was 
extracted with CH2Cl2 (2 × 50 mL) and the combined organic layers were 
dried over Na2SO4 and stripped down to 50 mL. To the solution was added 
DIPEA (6.55 mL, 37.7 mmol) and TBTU (8.87 g, 27.6 mmol), and the 
mixture was stirred for 5 min and cooled to 0 °C. To the solution was slowly 
added cyclohexyl amine (2.9 mL, 30.1 mmol) and the mixture stirred 10 
min at rt. Then, sat. aq. NaHCO3 (50 mL) was added and the layers 
separated. The aqueous phase was extracted with CH2Cl2 (2 × 50 mL) and 
the combined organic layers were dried over Na2SO4 and concentrated in 
vacuo. The residue was filtered through a silica plug (EtOAc:heptane 4:1, 
Rf = 0.2). The residue was taken up in THF (50 mL, 0.5 M) and stirred 
overnight at reflux where after it was concentrated in vacuo. The residue 
was purified by flash column chromatography (EtOAc:heptane 1:1, Rf = 
0.2) to give the title compound as a white solid (5.96 g, 67%). 1H NMR (400 
MHz, CDCl3) δ 7.57 (d, J = 8.3 Hz, 1H), 7.32 – 7.14 (m, 5H), 6.22 (dd, J = 
5.9, 1.5 Hz, 1H), 6.17 (d, J = 5.9 Hz, 1H), 4.95 (dd, J = 4.3, 1.4 Hz, 1H), 
3.81 (d, J = 12.7 Hz, 1H), 3.78 – 3.68 (m, 1H), 3.53 (d, J = 12.7 Hz, 1H), 
3.44 (s, 1H), 3.16 (dd, J = 8.3, 7.0 Hz, 1H), 2.21 (dd, J = 10.3, 8.9 Hz, 1H), 
1.89 – 1.73 (m, 3H), 1.69 – 1.50 (m, 4H), 1.39 – 1.02 (m, 6H); 13C NMR 
(101 MHz, CDCl3) δ 169.5, 138.4, 135.7, 134.7, 129.0 (2C), 128.7 (2C), 
127.6, 98.2, 80.1, 69.4, 59.8, 58.3, 47.5, 42.3, 33.7, 33.1, 29.7, 25.7, 24.9, 
24.8. HRMS (ESI) m/z: [M+H+] Calcd for C22H29N2O2 353.2224; Found 
353.2223. 
Representative procedure for the dihydroxylation. (±) 
(3R,3aR,4R,5S,6R,7aR)-2-benzyl-N-cyclohexyl-4,5-
dihydroxyoctahydro-3a,6-epoxyisoindole-3-carboxamide (2a). 
Compound 1a (5.26 g, 14.9 mmol) was dissolved in acetone (50 mL, 0.3 
M) and added N-methyl-morpholin-N-oxide (2.27 g, 19.4 mmol). 0.9% 
K2OsO4.2H2O (50 mg, 0.14 mmol) in H2O (5 mL) was added and stirred 
overnight at rt. Then H2O (50 mL) was added and the mixture was filtered. 
The filter cake was washed with H2O and heptane and then dried in vacuo 
to give the title compound as a white solid (5.06 g, 88%). 1H NMR (400 
MHz, CDCl3) δ 8.08 (d, J = 7.1 Hz, 1H), 7.32 – 7.10 (m, 5H), 6.56 (s, 1H), 
4.35 (d, J = 4.4 Hz, 1H), 3.91 (d, J = 5.6 Hz, 1H), 3.83 – 3.71 (m, 4H), 3.65 
(d, J = 11.8 Hz, 2H), 3.18 (t, J = 8.1 Hz, 1H), 2.31 (t, J = 9.2 Hz, 1H), 2.00 
(d, J = 7.4 Hz, 1H), 1.90 – 1.37 (m, 7H), 1.36 – 1.22 (m, 2H), 1.20 – 0.98 
(m, 3H); 13C NMR (101 MHz, CDCl3) δ 171.4, 138.0, 128.93(2C), 128.84 
(2C), 127.8, 97.3, 84.4, 75.3, 71.3, 68.6, 60.8, 59.7, 48.2, 42.1, 33.0, 32.5, 
31.0, 25.5, 24.72, 24.69. HRMS (ESI) m/z [M+H+] Calcd for C22H31N2O4 
387.2278; Found 387.2304. 
Representative procedure for the oxidative cleavage and aldehyde 
reduction. (±) (2R,3aR,6R,6aR)-5-benzyl-N-cyclohexyl-2,6a-
bis(hydroxymethyl)hexahydro-2H-furo[2,3-c]pyrrole-6-carboxamide 
(3a). Compound 2a (3.59 g, 9.29 mmol) was dispersed in MeOH:H2O (9:1, 
30 mL), added NaIO4 (2.98 g, 13.9 mmol) and the mixture was stirred at 
rt. After 1 h, water (50 mL) and CH2Cl2 (50 mL) were added and the layers 
were separated. The aqueous phase was extracted with CH2Cl2 (2 × 50 
mL) and the combined organic layers were concentrated in vacuo. The 
residue was dissolved in MeOH (30 mL), cooled to 0 °C and then added 
NaBH4 (850 mg, 20.4 mmol) portion wise. After stirring for 30 min at 0 °C 
the mixture was concentrated in vacuo. The residue was taken in CH2Cl2 
(50 mL) and sat. aq. NaHCO3 (50 mL) and the phases were separated. 
The aqueous phase was extracted with CH2Cl2 (2 × 50 mL) and the 
combined organic layers were dried over Na2SO4 and concentrated in 
vacuo. The residue was purified by flash column chromatography 
(EtOAc:MeOH 19:1, Rf = 0.2) to give the title compound as a white solid 
(3.36 g, 93%). 1H NMR (400 MHz, DMSO) δ 7.57 (d, J = 8.4 Hz, 1H), 7.38 
– 7.22 (m, 5H), 4.64 (dd, J = 6.2, 4.9 Hz, 1H), 4.39 (dd, J = 7.4, 4.8 Hz, 
1H), 4.07 (td, J = 8.8, 4.1 Hz, 1H), 3.71 (d, J = 12.9 Hz, 1H), 3.66 – 3.58 
(m, 1H), 3.55 (dt, J = 11.3, 4.1 Hz, 1H), 3.47 – 3.34 (m, 3H), 3.24 (d, J = 
12.9 Hz, 1H), 3.06 (t, J = 8.6 Hz, 1H), 3.00 (s, 1H), 2.61 (q, J = 8.2 Hz, 1H), 
2.07 (t, J = 8.8 Hz, 1H), 1.78 – 1.61 (m, 5H), 1.60 – 1.45 (m, 2H), 1.32 – 
1.18 (m, 4H), 1.21 – 1.03 (m, 1H); 13C NMR (101 MHz, DMSO) δ 168.2, 
138.0, 128.7 (2C), 128.2 (2C), 127.0, 94.6, 79.3, 76.4, 63.5, 62.6, 57.3, 
57.1, 47.2, 43.7, 33.0, 32.23, 32.18, 25.1, 24.7, 24.6. HRMS (ESI) m/z 
[M+H+] Calcd for C22H33N2O4 389.2440; Found 389.2448. 
(±) ((2R,3aR,6R,6aR)-5-benzyl-6-(cyclohexylcarbamoyl)hexahydro-
6aH-furo[2,3-c]pyrrole-2,6a-diyl)bis(methylene) dimethanesulfonate 
(4a). Compound 3a (2.17 g, 5.62 mmol) was dissolved in CH2Cl2 (28 mL), 
added Et3N (2.36 mL, 18.9 mmol) and cooled to 0 °C. Then MsCl (1.37 
mL, 11.2 mmol) was added slowly. After 10 min, water (50 mL) and CH2Cl2 
(25 mL) was added and the layers were separated. The aqueous phase 
was extracted with CH2Cl2 (2 × 50 mL) and the combined organic layers 
were dried over Na2SO4 and concentrated in vacuo. To the residue was 
added heptane and the mixture was filtered to provide the title compound 
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as a white solid (3.02 g, 99%). 1H NMR (400 MHz, CDCl3) δ 7.40 – 7.22 
(m, 5H), 6.93 (s, 1H), 4.46 (s, 1H), 4.37 – 4.24 (m, 3H), 4.21 (d, J = 10.5 
Hz, 1H), 3.93 (d, J = 12.9 Hz, 1H), 3.87 – 3.75 (m, 1H), 3.41 – 3.10 (m, 
3H), 3.08 (s, 3H), 3.03 (s, 3H), 2.84 (dd, J = 15.5, 8.5 Hz, 1H), 2.22 (s, 1H), 
2.00 – 1.83 (m, 3H), 1.81 – 1.67 (m, 3H), 1.66 – 1.56 (m, 1H), 1.46 – 1.30 
(m, 2H), 1.28 – 1.11 (m, 3H). 13C NMR (101 MHz, CDCl3) δ 167.5, 136.9, 
128.9 (2C), 128.8 (2C), 128.0, 93.1, 77.1, 70.9, 70.2, 58.7, 56.9, 48.1, 
46.1, 44.7, 37.7, 37.5, 33.1, 32.2, 25.5, 24.9, 24.9, 8.7. HRMS (ESI) m/z 
[M+H+] Calcd for C24H37N2O8S2 545.1986; Found 545.1998. 
(±) ((2R,3aR,5aR,8aS)-5-benzyl-7-cyclohexyl-6-oxooctahydro-2H-
furo[2,3-c]pyrrolo[3,4-b]pyrrol-2-yl)methyl methanesulfonate (5a). 
Compound 3a (568 mg, 1.46 mmol) was dissolved in dry THF (5 mL), 
added Et3N (630 µL, 4.39 mmol) and cooled to 0 °C. Then MsCl (250 µL, 
3.22 mmol) was added. After stirring for 15 min, 55% NaH in mineral oil 
(255 mg, 8.77 mmol) was added and the mixture was stirred 2 h at 60 °C. 
The mixture was then cooled to rt and added H2O (50 mL) and sat. aq. 
NaHCO3 (10 mL), followed by CH2Cl2 (50 mL). The layers were separated  
and the aqueous phase was extracted with CH2Cl2 (2 x 25 mL) and the 
combined organic layers were concentrated in vacuo. The residue was 
purified by flash column chromatography (EtOAc:heptane 3:2, Rf = 0.2) to 
give the title compound as a white solid (618 mg, 94%). 1H NMR (400 MHz, 
CDCl3) δ 7.35 (d, J = 7.1 Hz, 2H), 7.33 – 7.27 (m, 2H), 7.23 (t, J = 7.1 Hz, 
1H), 4.51 – 4.38 (m, 1H), 4.34 (dd, J = 11.1, 2.9 Hz, 1H), 4.17 (dd, J = 
11.1, 5.7 Hz, 1H), 4.10 (d, J = 6.2 Hz, 1H), 4.03 – 3.94 (m, 1H), 3.51 – 3.41 
(m, 3H), 3.05 (s, 3H), 2.84 (dd, J = 9.2, 6.8 Hz, 1H), 2.67 – 2.59 (m, 1H), 
2.55 (dd, J = 9.3, 4.2 Hz, 1H), 2.04 – 1.91 (m, 1H), 1.88 – 1.76 (m, 3H), 
1.78 – 1.59 (m, 3H), 1.44 – 1.22 (m, 5H), 1.15 – 1.02 (m, 1H). 13C NMR 
(101 MHz, DMSO) δ 169.7, 138.8, 128.5 (2C), 128.2 (2C), 126.8, 92.3, 
77.0, 71.0, 71.0, 57.7, 55.3, 51.2, 49.7, 47.6, 36.7, 33.0, 29.5, 29.4, 25.1, 
25.0, 24.9. HRMS (ESI) m/z [M+H+] Calcd for C23H33N2O5S 449.2105; 
found 449.2157. 
(±) (2R,3aR,5aR,8aS)-5-benzyl-7-cyclohexyl-2-(pyrrolidin-1-
ylmethyl)octahydro-6H-furo[2,3-c]pyrrolo[3,4-b]pyrrol-6-one (6a). 
Compound 4a (345 mg, 0.633 mmol) was dissolved in dry THF (4 mL), 
cooled to 0 °C and added 55% NaH (83 mg, 1.90 mmol) and the mixture 
was stirred 10 min. Then the reaction mixture was stirred at reflux for 30 
min, whereupon NaI (190 mg, 1.27 mmol) and  pyrrolidine (0.211 mL, 1.27 
mmol) was added and the mixture was stirred at reflux for another 6 h. The 
reaction was then cooled to 0 °C and water (40 mL) was added followed 
by CH2Cl2 (50 mL). The layers were separated and the aquouse phase 
was extracted with CH2Cl2 (2 × 50 mL) and the combined organic layers 
were dried over Na2SO4 and concentrated in vacuo. The residue was 
purified by flash column chromatography (MeOH:CH2Cl2 1:9, Rf = 0.2) to 
give the title compound as an amourphous yellow solid (189 mg, 71%). 1H 
NMR (400 MHz, CDCl3) δ 7.34 (d, J = 7.1 Hz, 2H), 7.31 – 7.24 (m, 2H), 
7.20 (t, J = 7.1 Hz, 1H), 4.48 – 4.30 (m, 1H), 4.16 (d, J = 13.3 Hz, 1H), 4.03 
– 3.91 (m, 2H), 3.52 – 3.41 (m, 2H), 3.35 (s, 1H), 2.90 – 2.78 (m, 6H), 2.72 
(dd, J = 12.9, 7.8 Hz, 1H), 2.57 – 2.51 (m, 1H), 2.46 (dd, J = 9.3, 5.1 Hz, 
1H), 1.96 – 1.84 (m, 3H), 1.83 – 1.62 (m, 8H), 1.43 – 1.22 (m, 4H), 1.16 – 
0.97 (m, 1H); 13C NMR (101 MHz, CDCl3) δ 170.9, 139.1, 128.9 (2C), 
128.3 (2C), 126.9, 92.6, 77.4, 71.8, 59.7, 58.2, 56.0, 54.6 (2C), 51.9, 50.2, 
48.6, 37.0, 30.3, 30.2, 25.51, 25.49, 25.4, 23.4 (2C). HRMS (ESI) m/z 
[M+H+] Calcd for C26H38N3O2 424.2959; Found 424.2974. 
(±) (3a'R,5a'R,8a'S)-5'-benzyl-7'-cyclohexyl-1-
methylhexahydrospiro[azetidine-3,2'-furo[2,3-c]pyrrolo[3,4-b]pyrrol]-
6'(3'H)-one (9a). Compound 3f (100 mg/0.19 mmol) was dissolved in 
CH2Cl2 (2 mL, 0.1 M), added Et3N (79 µL, 0,56 mmol) and cooled to 0 °C. 
Then MsCl (33.4 µL, 0.56 mmol was added slowly. After 10 min, water (50 
mL) and CH2Cl2 (25 mL) were added and the layers were separated. The 
aqueous phase was extracted with CH2Cl2 (2 × 50 mL) and the combined 
organic layers were dried over Na2SO4 and concentrated in vacuo. The 
crude was dissolved in 30% of TFA in DCM (2 mL) and stirred at room 
temperature for 2 h. A sat aq NaHCO3 was added slowly until neutralization 
of the acid and the aqueous phase extracted with CH2Cl2 (3 x 50 mL). The 
combined organic layers were dried over Na2SO4, filtered and 
concentrated under reduced pressure. The crude was solubilized in dry 
THF (10 mL) and 55 % NaH (25 mg/0.56 mmol) was added slowly. The 
mixture was stirred at reflux for 2 hours. Then, it was cooled to room 
temperature and NaI (56 mg, 0.38 mmol) and dry DMF (2 mL) were added 
and stirred for 4 hours. 50 mL of water were added to the reaction and 
extracted with ethyl acetate (3 x 50 mL). The combined organic phases 
were washed with brine (2 x 50 mL), dried over Na2SO4, filtered and 
concentrated. The crude was purified by silica gel flash chromatography 
(MeOH (5% NH4OH (30% aq.)):CH2Cl2, 96:4, Rf = 0.3) to give the title 
compound as a light yellow oil (26 mg/35 %). 1H NMR (400 MHz, CDCl3) δ 
7.37 – 7.32 (m, 2H), 7.32 – 7.26 (m, 2H), 7.25 – 7.17 (m, 1H), 4.15 (d, J = 
13.2 Hz, 1H), 4.03 (d, J = 13.2 Hz, 1H), 4.01 – 3.93 (m, 1H), 3.52-3.49 (m, 
1H), 3.46 – 3.39 (m, 3H), 3.35 (d, J = 10.1 Hz, 1H), 3.15-3-10 (m, 2H), 2.75 
(dd, J = 9.7, 7.1 Hz, 1H), 2.61 – 2.51 (m, 2H), 2.36 (s, 3H), 2.28 (dd, J = 
12.9, 9.4 Hz, 1H), 2.13 (dd, J = 12.9, 3.3 Hz, 1H), 1.84 – 1.61 (m, 5H), 1.45 
– 1.21 (m, 4H), 1.09-1.04 (m, 1H); 13C NMR (101 MHz, CDCl3) δ 170.5, 
139.1, 129.1 (2C), 128.2 (2C), 127.0, 92.2, 80.1, 70.9, 69.8, 67.7, 57.7, 
55.1, 51.6, 50.2, 49.6, 46.1, 42.3, 30.4, 30.2, 25.53, 25.50, 25.47. HRMS 
(ESI) m/z [M+H+] Calcd for C24H34N3O2 396.2646; Found 393.2656. 
Representative procedure for substitution with phenols. (±) 
(2R,3aR,5aR,8aS)-5-benzyl-7-butyl-2-((3-
fluorophenoxy)methyl)octahydro-6H-furo[2,3-c]pyrrolo[3,4-b]pyrrol-
6-one (7c). Compound 3c (353 mg, 0.97 mmol) was dissolved in THF (10 
mL), added Et3N (0.407 mL, 2.92 mmol) and cooled to 0 °C. Then MsCl 
(0.196 mL, 2.4 mmol) was added slowly. After 10 min, water (10 mL) and 
CH2Cl2 (10 mL) were added and the layers separated. The aqueous phase 
was extracted with CH2Cl2 (2 × 10 mL) and the combined organic layers 
were dried using Na2SO4 and concentrated in vacuo. The crude was 
dissolved in dry THF (5 mL), cooled to 0 °C and added 55% NaH (255 mg, 
5.85 mmol) and stirred 10 min. Then, the reaction mixture was stirred at 
60 oC for 1h. The reaction was cooled to room temperature and quenched 
with water (5 mL) and extracted with DCM (3 x 5 mL). The combined 
organic layers were dried using Na2SO4 and concentrated in vacuo. The 
residue was taken up in DMF (5 mL) and Cs2CO3 (952 mg, 2.92 mmol) 
and 3-fluorophenol (0.26 mL, 2.92 mmol) were added and heated at 90 oC 
for 1h. The reaction was cooled to room temperature and water (20 mL) 
and EtOAc (20 mL) were added and the layers separated. The aqueous 
phase was extracted with EtOAc (2 x 20 mL) and the combined organic 
layers were washed with NaOH 1M (2 x 20 mL), brine (2 x 20 mL), dried 
over Na2SO4 and concentrated in vacuo. The residue was purified by semi-
automated flash chromatography (Puriflash ® 25g, EtOAc in heptane (5 to 
45%); EtOAc:heptane 1:1, Rf = 0.45) to give the compound as a viscous 
oil that solidifies upon standing (179 mg, 42%). 1H NMR (400 MHz, CDCl3) 
δ 7.45 (d, J = 7.2 Hz, 2H), 7.38 (t, J = 7.2 Hz, 2H), 7.34 – 7.24 (m, 2H), 
6.80 – 6.68 (m, 3H), 4.65 – 4.52 (m, 1H), 4.28 (d, J = 13.4 Hz, 1H), 4.12 – 
4.07 (m, 2H), 4.03 (dd, J = 10.0, 5.6 Hz, 1H), 3.64 (d, J = 10.4 Hz, 1H), 
3.57 (d, J = 10.4 Hz, 1H), 3.53 (s, 1H), 3.45 – 3.29 (m, 2H), 2.98 (dd, J = 
9.3, 7.0 Hz, 1H), 2.84 – 2.68 (m, 1H), 2.59 (dd, J = 9.4, 5.1 Hz, 1H), 2.07 
(dt, J = 12.5, 9.1 Hz, 1H), 1.96 (ddd, J = 12.5, 6.0, 2.2 Hz, 1H), 1.66 – 1.51 
(m, 2H), 1.49 – 1.35 (m, 2H), 1.01 (t, J = 7.3 Hz, 3H); 13C NMR (101 MHz, 
CDCl3) δ 171.3, 163.6 (d, JCF = 245.3 Hz), 160.1 (d, JCF = 10.8 Hz), 138.9, 
130.3 (d, JCF = 10.0 Hz), 128.9 (2C), 128.2 (2C), 126.9, 110.4 (d, JCF = 2.8 
Hz), 107.9 (d, JCF = 21.3 Hz), 102.4 (d, JCF = 24.9 Hz), 92.7, 78.2, 71.4, 
70.2, 58.1, 56.0, 55.9, 49.0, 41.8, 34.5, 29.1, 20.0, 13.9. HRMS (ESI) m/z 
[M+H+] Calcd for C26H32FN2O4 437.2391; Found 437.2409. 
Representative procedure for the substitution with phthalimide. (±) 2-
(((2R,3aR,5aR,8aS)-5-benzyl-7-butyl-6-oxooctahydro-2H-furo[2,3-
c]pyrrolo[3,4-b]pyrrol-2-yl)methyl)isoindoline-1,3-dione (8b). 
Compound 3c (306 mg, 0.84 mmol) was dissolved in THF (8 mL), added 
Et3N (0.351 mL, 2.5 mmol) and cooled to 0 °C. Then MsCl (0.164 mL, 2.12 
mmol) was added slowly. After 10 min, water (10 mL) and CH2Cl2 (10 mL) 
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was added and the layers were separated. The aqueous phase was 
extracted with CH2Cl2 (2 × 10 mL) and the combined organic layers were 
dried over Na2SO4 and concentrated in vacuo. The crude was dissolved in 
dry THF (8 mL), cooled to 0 °C, added 55% NaH (220 mg, 5 mmol) and 
stirred 10 min. Then, the reaction mixture was stirred at 60 oC for 1h. The 
reaction was cooled to room temperature and quenched with water (10 
mL) and extracted with DCM (3 x 10 mL). The combined organic layers 
were dried over Na2SO4 and concentrated in vacuo. The residue was taken 
up in DMF (5 mL) and potassium phthalimide (233 mg, 1.26 mmol) was 
added and heated at 90 oC for 16 h. The reaction was cooled to room 
temperature and water (10 mL) and CH2Cl2 were added and the layers 
separated. The aqueous phase was extracted with CH2Cl2 (2 x 10 mL) and 
the combined organic layers were dried over Na2SO4 and concentrated in 
vacuo. The residue was purified by flash column chromatography 
(EtOAc:heptane, Rf = 0.1) to give the title compound as a white solid (192 
mg, 48%). 1H NMR (400 MHz, CDCl3) δ 7.86 (dd, J = 5.5, 3.0 Hz, 2H), 7.73 
(dd, J = 5.5, 3.0 Hz, 2H), 7.36 – 7.29 (m, 2H), 7.29 – 7.25 (m, 2H), 7.24 – 
7.17 (m, 1H), 4.48 (tt, J = 12.1, 6.0 Hz, 1H), 4.16 (d, J = 13.4 Hz, 1H), 3.94 
(d, J = 13.4 Hz, 1H), 3.84 (dd, J = 13.9, 7.4 Hz, 1H), 3.73 (dd, J = 13.9, 4.7 
Hz, 1H), 3.54 (d, J = 10.5 Hz, 1H), 3.48 (d, J = 10.5 Hz, 1H), 3.33 (s, 1H), 
3.28 (td, J = 7.1, 1.5 Hz, 2H), 2.84 (dd, J = 9.3, 6.9 Hz, 1H), 2.63 (dq, J = 
7.0, 4.7 Hz, 1H), 2.45 (dd, J = 9.4, 5.0 Hz, 1H), 1.96 – 1.81 (m, 2H), 1.56 
– 1.44 (m, 2H), 1.37 – 1.26 (m, 2H), 0.93 (t, J = 7.3 Hz, 3H); 13C NMR (101 
MHz, CDCl3) δ 171.4, 168.4 (2C), 139.1, 134.2 (2C), 132.1 (2C), 128.9 
(2C), 128.3 (2C), 127.0, 123.5 (2C), 92.4, 77.3, 71.4, 57.8, 56.3, 56.0, 
49.1, 42.0, 41.9, 36.0, 29.2, 20.1, 13.9. HRMS (ESI) m/z [M+H+] Calcd for 
C28H32N3O4 474.2387; Found 474.2368. 
Representative procedures for the N-benzyl deprotection. (±) 
(2R,3aR,5aR,8aS)-7-cyclohexyl-2-(phenoxymethyl)octahydro-6H-
furo[2,3-c]pyrrolo[3,4-b]pyrrol-6-one (10a). Deprotection with 1-
chloroethyl chloroformate. Compound 7a (160 mg, 0.36 mmol) was 
taken in dry dichloromethane (10 mL), placed under nitrogen at 0 oC and 
1-chloroethyl chloroformate was added dropwise (58 µL, 0.54 mmol). The 
reaction was heated at reflux until no starting material was present. The 
solvent was evaporated under reduced pressure and the crude taken up 
in methanol where it was stirred for 30 min under reflux. The solvent was 
evaporated and the solid obtained was triturated with diethyl ether. The 
solid was washed twice with diethyl ether to give the compound as a white 
solid (141 mg/quant). The crude was used directly in the next step without 
further purification. (±) (2R,3aR,5aR,8aS)-7-(2-methoxyethyl)-2-
(phenoxymethyl)octahydro-6H-furo[2,3-c]pyrrolo[3,4-b]pyrrol-6-one (10b). 
Deprotection by hydrogenation. Compound 7b (75 mg, 0.178 mmol) 
was dissolved in MeOH (5 mL) and 20 % Pd(OH)2/C (24 mg) and 
HCOONH4 (112 mg, 1.78 mmol) was added and the mixture was stirred 
for 24h at reflux. The mixture was then filtered over a pad of celite and 
washed with ethyl acetate and CH2Cl2. The solvent was evaporated to give 
the title compound as a yellow oil (59 mg/quant). The crude was used 
directly in the next step without further purification. 
Representative procedure for the urea formation using isocyanates. 
(±) (2R,3aR,5aR,8aS)-7-cyclohexyl-6-oxo-2-(phenoxymethyl)-N-(o-
tolyl)octahydro-5H-furo[2,3-c]pyrrolo[3,4-b]pyrrole-5-carboxamide 
(11a). Amine salt 10a (20 mg, 0.051 mmol) was taken in DMF (1 mL), 
DIPEA (21 μL, 0.122 mmol) and o-tolyl isocyanate (10 μL, 0.061 mmol) 
was added and the mixture was stirred 1 h at rt. The compound was then 
purified directly by preparative HPLC to give the title compound as a white 
powder (13 mg, 53%). 1H NMR (400 MHz, CDCl3) δ 9.10 (s, 1H), 7.70 (d, 
J = 8.0 Hz, 1H), 7.31 (dd, J = 8.6, 7.4 Hz, 2H), 7.20 – 7.12 (m, 2H), 7.03 – 
6.89 (m, 4H), 4.75 – 4.62 (m, 1H), 4.50 (s, 1H), 4.15 (dd, J = 10.3, 3.0 Hz, 
1H), 4.05 – 3.99 (m, 1H), 3.97 (dd, J = 10.3, 4.5 Hz, 1H), 3.81 (dd, J = 
11.2, 8.5 Hz, 1H), 3.61 (dd, J = 11.2, 8.9 Hz, 1H), 3.50 (d, J = 10.6 Hz, 
1H), 3.43 (d, J = 10.6 Hz, 1H), 2.83 (q, J = 7.5 Hz, 1H), 2.35 (s, 3H), 2.23 
(ddd, J = 13.1, 9.2, 7.0 Hz, 1H), 2.12 (ddd, J = 13.1, 6.3, 1.3 Hz, 1H), 1.90 
– 1.63 (m, 5H), 1.49 – 1.27 (m, 4H), 1.20 – 1.02 (m, 1H); 13C NMR (101 
MHz, CDCl3) δ 171.0, 162.2, 158.7, 156.5, 137.7, 130.4, 129.7, 128.8, 
126.4, 123.4, 122.3, 121.4, 114.6, 93.3, 78.6, 69.6, 68.0, 51.9, 51.6, 51.0, 
47.7, 31.0, 30.3, 30.0, 25.42, 25.35, 25.28, 18.6. HRMS (ESI) m/z [M+H+] 
Calcd for C29H36N3O4 490.2700; Found 490.2669. 
Representative procedure for acylation using acyl chlorides. (±) 
(2R,3aR,5aR,8aS)-7-(2-methoxyethyl)-2-(phenoxymethyl)-5-
(thiophene-2-carbonyl)octahydro-6H-furo[2,3-c]pyrrolo[3,4-b]pyrrol-
6-one (13a). Amine salt 10b (20 mg, 0.06 mmol) was taken up in DMF 
(1mL), DIPEA (16 µL, 0.09 mmol) was added followed by 2-
thiophenecarbonyl chloride (9.6 µL, 0.09 mmol) and the mixture was 
stirred 1h at rt. The compound was then purified directly by preparative 
HPLC to give the title compound as a white amorphous solid (7 mg, 26%). 
1H NMR (400 MHz, CDCl3) δ 8.13 (broad s, 1H), 7.52 (dd, J = 5.0, 1.0 Hz, 
1H), 7.37 – 7.31 (m, 2H), 7.08 (dd, J = 5.0, 3.8 Hz, 1H), 7.00 (tt, J = 7.5, 
1.0 Hz, 1H), 6.97 – 6.90 (m, 2H), 4.99 (s, 1H), 4.49 (tq, J = 8.0, 4.7, 4.0 
Hz, 1H), 4.36 (d, J = 13.0 Hz, 1H), 4.06 (dd, J = 10.1, 3.2 Hz, 1H), 3.95 
(dd, J = 10.1, 4.8 Hz, 1H), 3.78 (d, J = 10.5 Hz, 1H), 3.74 – 3.48 (m, 6H), 
3.38 (s, 3H), 2.96 (tq, J = 8.8, 4.0 Hz, 1H), 2.29 (dt, J = 12.9, 8.3 Hz, 1H), 
2.12 (broad s, 1H). 13C NMR (101 MHz, CDCl3) δ 169.4, 163.8, 158.5, 
137.9, 130.9, 130.0, 129.5 (2C), 127.3, 121.2, 114.5 (2C), 93.7, 79.1, 70.4, 
69.8, 68.8, 58.8, 55.4, 51.2, 47.5, 42.8, 34.9. HRMS (ESI) m/z [M+H+] 
Calcd for C23H27N2O5S 443.1635; Found 443.1652. 
¨Representative procedure for reductive alkylation using aldehydes. 
(±) (2R,3aR,5aR,8aS)-7-cyclohexyl-5-((5-methylthiophen-2-yl)methyl)-
2-(phenoxymethyl)octahydro-6H-furo[2,3-c]pyrrolo[3,4-b]pyrrol-6-
one (14a). Amine salt 10a (18 mg, 0.046 mmol) was taken up in DMF (1 
mL) and DIPEA (9 μL, 0.069 mmol), 5-methylthiophene-2-carbaldehyde (9 
mg, 0.069 mmol), and NaBH(OAc)3 (15 mg, 0.069 mmol) was added and 
the mixture was stirred for 16 h at rt. The compound was then purified 
directly by preparative HPLC to give a white powder (12 mg, 54%). 1H 
NMR (400 MHz, CDCl3) δ 7.29 (dd, J = 8.7, 7.4 Hz, 2H), 6.96 (t, J = 7.4 
Hz, 1H), 6.94 – 6.89 (m, 2H), 6.74 (d, J = 3.1 Hz, 1H), 6.56 (dd, J = 3.1, 
1.0 Hz, 1H), 4.61 – 4.48 (m, 1H), 4.31 (d, J = 14.2 Hz, 1H), 4.20 (d, J = 
14.2 Hz, 1H), 4.04 (dd, J = 10.1, 3.5 Hz, 1H), 4.00 – 3.94 (m, 2H), 3.57 (s, 
1H), 3.52 (d, J = 10.3 Hz, 1H), 3.48 (d, J = 10.3 Hz, 1H), 2.95 – 2.80 (m, 
1H), 2.71 (dd, J = 9.3, 4.1 Hz, 1H), 2.70 – 2.61 (m, 1H), 2.44 (s, 3H), 2.10 
– 1.99 (m, 1H), 1.95 (ddd, J = 12.4, 6.2, 2.7 Hz, 1H), 1.85 – 1.61 (m, 5H), 
1.47 – 1.21 (m, 4H), 1.14 – 1.00 (m, 1H); 13C NMR (101 MHz, CDCl3) δ 
170.7, 158.9, 140.5, 139.2, 129.6 (2C), 125.7, 124.6, 121.2, 114.7 (2C), 
92.7, 78.7, 77.4, 71.1, 70.2, 57.5, 51.8, 50.3, 50.1, 49.4, 35.0, 30.4, 30.2, 
25.6, 25.5, 15.6. HRMS (ESI) m/z [M+H+] calcd for C27H35N2O3S 467.2363; 
Found 467.2380. 
Representative procedure for phthalimide deprotection. (±) 
(2R,3aR,5aR,8aS)-2-(aminomethyl)-5-benzyl-7-butyloctahydro-6H-
furo[2,3-c]pyrrolo[3,4-b]pyrrol-6-one (15a). Compound 8a (126 mg, 
0.27 mmol) was taken up in EtOH (4 mL) and hydrazine monohydrate (39 
µL, 0.80 mmol) was added and the mixture was stirred 2 h at reflux. The 
mixture was then cooled to rt and the mixture was filtered. The filter cake 
was washed with CH2Cl2 and the filtrate was concentrated in vacuo. The 
residue was resolved in CH2Cl2 and the mixture was filtered again and then 
concentrated in vacuo to give the title compound as colorless oil (91 mg, 
quant.), that was used directly in the next step without further purification. 
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